Doctronic, a New York-based startup developing an AI-powered virtual primary care platform, has raised $40 million in Series B funding. The round will be used to expand its AI diagnostic capabilities, scale clinical operations across the US, enhance its multilingual and culturally adaptive models, and accelerate partnerships with employers, health plans, and telehealth providers to deliver accessible, on-demand primary care.
Glimpse:
Doctronic’s AI doctor platform combines advanced large language models with real-time symptom analysis, medical knowledge retrieval, and clinical reasoning to provide accurate preliminary assessments, treatment recommendations, and triage decisions. The $40 million Series B, led by prominent healthtech and AI-focused investors, will support regulatory expansion, model fine-tuning on diverse patient populations, integration with major EHR systems, and growth of its hybrid care model that pairs AI with human physicians for complex cases. The company aims to reduce unnecessary ER visits, shorten wait times for primary care, and improve chronic disease management at scale.
Doctronic, a fast-rising New York-based healthtech startup building an AI-powered virtual primary care platform, has successfully closed a $40 million Series B funding round. The investment, announced on February 26, 2026, was led by a syndicate of top-tier venture capital firms with deep expertise in AI and healthcare, including participation from strategic healthcare investors and existing backers. This brings Doctronic’s total funding to date to over $65 million since its founding in 2023.
The company’s core offering is an advanced AI doctor system that engages patients through a conversational interface, analyzes symptoms, medical history, and available data, and delivers clinically reasoned assessments, differential diagnoses, treatment recommendations, and triage guidance. Unlike generic symptom checkers, Doctronic’s platform is built on large language models fine-tuned with extensive medical knowledge, real-world clinical pathways, and continuous feedback from licensed physicians. It operates in a hybrid model where the AI handles initial consultations and routine follow-ups, while human doctors review complex or high-risk cases and provide final medical decisions.
The fresh capital will be deployed to accelerate several strategic priorities: expanding the AI model’s capabilities across additional medical specialties, scaling clinical operations to serve more states, enhancing multilingual and culturally adaptive features for diverse patient populations, and deepening integrations with major electronic health record systems and employer health platforms. Doctronic also plans to invest in regulatory and compliance infrastructure to support broader adoption by health plans, self-insured employers, and telehealth networks.
Doctronic’s founders highlighted that the funding comes at a critical time when demand for accessible, affordable primary care continues to outstrip supply in the United States. By combining the scalability of AI with the safety net of human oversight, the platform aims to reduce unnecessary emergency room visits, shorten wait times for routine care, and improve chronic disease management and preventive health outcomes at population scale.
The Series B round reflects strong investor confidence in the potential of responsible, clinically grounded AI to address structural challenges in primary care delivery. With this capital, Doctronic is well-positioned to expand its reach and solidify its role as a leader in the emerging category of AI-augmented virtual care.
“Our goal is simple: make high-quality primary care available to everyone, anytime, anywhere powered by AI that is safe, accurate, and always backed by human doctors when it matters most.”
By
HB Team
Related News
